What is he best known for?
The fields of study he is best known for:
Mark H. Rider mainly investigates Biochemistry, Protein kinase A, Cell biology, Phosphorylation and AMPK.
His study in Protein kinase A is interdisciplinary in nature, drawing from both Glycogen synthase, P70-S6 Kinase 1 and Spliceosome.
Mark H. Rider studies Cell biology, focusing on MAP2K7 in particular.
His work investigates the relationship between MAP2K7 and topics such as Mitogen-activated protein kinase kinase that intersect with problems in Cyclin-dependent kinase 2.
His work in Phosphorylation addresses issues such as Kinase, which are connected to fields such as Adenylate kinase, Adenine nucleotide and Signal transduction.
His Glycolysis research is multidisciplinary, incorporating perspectives in Fructose, Oxidative phosphorylation and Phosphofructokinase 2.
His most cited work include:
- Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. (654 citations)
- Role of PFKFB3-Driven Glycolysis in Vessel Sprouting (644 citations)
- Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis (391 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Biochemistry, Protein kinase A, Cell biology, Phosphorylation and AMPK.
He regularly ties together related areas like Molecular biology in his Biochemistry studies.
When carried out as part of a general Protein kinase A research project, his work on Mitogen-activated protein kinase kinase is frequently linked to work in EEF2, therefore connecting diverse disciplines of study.
His Cell biology research incorporates themes from GLUT4 and GRB10.
His work on Protein kinase B, P70-S6 Kinase 1 and Protein phosphorylation as part of general Phosphorylation study is frequently connected to Ribosomal protein s6, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His biological study spans a wide range of topics, including Glucose transporter, Endocrinology, Glucose uptake and Internal medicine.
He most often published in these fields:
- Biochemistry (61.07%)
- Protein kinase A (36.24%)
- Cell biology (29.53%)
What were the highlights of his more recent work (between 2015-2020)?
- AMPK (26.85%)
- Cell biology (29.53%)
- Biochemistry (61.07%)
In recent papers he was focusing on the following fields of study:
Mark H. Rider spends much of his time researching AMPK, Cell biology, Biochemistry, Protein kinase A and Internal medicine.
His research in AMPK intersects with topics in Glucose uptake, Activator, Insulin resistance and Skeletal muscle.
His Cell biology research is multidisciplinary, incorporating elements of Phosphofructokinase 2, PFKFB4, Na+/K+-ATPase and Cell growth.
His work in the fields of Biochemistry, such as Enzyme, Metabolite and Intracellular, overlaps with other areas such as Tau isoforms and Absolute quantification.
His work in Protein kinase A covers topics such as Adenine nucleotide which are related to areas like Adenylate kinase, Signal transduction, Catabolism and Anabolism.
His studies deal with areas such as Nuclear receptor and Endocrinology as well as Internal medicine.
Between 2015 and 2020, his most popular works were:
- AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B (70 citations)
- A conserved phosphatase destroys toxic glycolytic side products in mammals and yeast (56 citations)
- Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle (34 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Biochemistry, Cell biology, AMPK, Pentose phosphate pathway and Phosphorylation.
The various areas that he examines in his Biochemistry study include Internal medicine and Muscle contraction.
His Cell biology research is multidisciplinary, incorporating perspectives in PFKFB4, Phosphofructokinase 2, Allosteric regulation and Cancer research.
AMPK is a subfield of Protein kinase A that Mark H. Rider investigates.
The concepts of his Pentose phosphate pathway study are interwoven with issues in Metabolite, Phosphatase, Pyruvate kinase and Metabolic pathway.
His Phosphorylation study combines topics from a wide range of disciplines, such as Signal transduction, Adenylate kinase, Kinase and Adenine nucleotide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
